Challenging a bid from Ventana Medical Systems, Cytyc (diagnostics and devices for cancer and women's health) intends to offer $A497mm ($374mm) for Australian in vitro diagnostics maker Vision Systems. (Sep.)
Cytyc plans to bid $A2.35 in cash for each ordinary share, a 10% premium to both Vision System's market average and the $A2.13 per share offer from Ventana last month....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?